Antithrombotic Drugs: Part II

Medicine and Dentistry

• Inpatient 100%
• Antithrombotic 100%
• Dextran 83%
• Therapeutic Procedure 50%
• Venous Thromboembolism 50%
• Surgery 33%
• Drug 33%
• Chemotherapeutic Agent 33%
• Thromboembolism 33%
• Heparin 33%
• Fibrinolytic Therapy 33%
• Coronary Artery Disease 33%
• Pulmonary Embolism 33%
• Peripheral Artery 33%
• Cerebrovascular Disease 33%
• Thrombus 33%
• Thrombocyte Function 33%
• Patient 16%
• Evaluation Study 16%
• Disease 16%
• Combination Therapy 16%
• Myocardial Infarction 16%
• Blood 16%
• Syndrome 16%
• Man 16%
• In Vitro 16%
• Streptokinase 16%
• Thrombolytic Drug 16%
• Acetylsalicylic Acid 16%
• Proteinase 16%
• Haemophilus Influenzae Type B Vaccine 16%
• Ischemia 16%
• Arterial Thromboembolism 16%
• Embolism 16%
• Fibrinolysin 16%
• Thrombosis 16%
• Intravenous Drug Administration 16%
• Urokinase 16%
• Allergic Response 16%
• Phlebothrombosis 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticoagulant Agent 100%
• Dextran 83%
• Plasminogen Activator 83%
• Venous Thromboembolism 50%
• Fibrinolytic Agent 50%
• Drug 33%
• Clinical Trial 33%
• Thromboembolism 33%
• Heparin 33%
• Coronary Artery Disease 33%
• Cerebrovascular Disease 33%
• Lung Embolism 33%
• Thrombus 33%
• Diseases 16%
• Allergic Reaction 16%
• Proteinase 16%
• Syndrome 16%
• Sulfinpyrazone 16%
• Heart Infarction 16%
• Vein Thrombosis 16%
• Ischemia 16%
• Acetylsalicylic Acid 16%
• Arterial Thromboembolism 16%
• Glucose Polymer 16%
• Embolism 16%
• Thrombosis 16%
• Artery Thrombosis 16%
• Urokinase 16%
• Streptokinase 16%
• Dextran 70 16%
• Dextran 40 16%
• Ancrod 16%
• Haemophilus Influenzae Type B Vaccine 16%